constipated from glp 1 Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms Constipation & Weight Loss Medications

The FLOW trial (semaglutide) and SUMMIT trial (tirzepatide) extended these findings to people with obesity without diabetes, demonstrating that GLP-1 medications reduce cardiovascular risk even in this population

This article explains the relationship between milligrams and units, proper dosing techniques, and critical safety considerations for semaglutide administration

Our specialists at Set Point Medical Weight Loss Clinic offer GLP-1 Medical Weight Loss programs tailored to your individual needs, providing comprehensive support and guidance throughout your weight loss journey

Some individuals may experience side effects such as nausea, gallbladder issues, or kidney problems

According to NICE guidance on type 2 diabetes management (NG28), treatment should be individualised, and medications causing intolerable side effects should be reviewed

For weight loss patients, the emphasis shifts toward side effect management, expectations around weight trajectories, and the importance of adherence